Mega Lifesciences PCL (MEGA)

Currency in THB
37.00
+0.50(+1.37%)
Closed·
Unusual trading volume
High dividend Yield
MEGA is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
36.2537.00
52 wk Range
24.3037.25
Key Statistics
Bid/Ask
36.75 / 37.00
Prev. Close
36.5
Open
36.5
Day's Range
36.25-37
52 wk Range
24.3-37.25
Volume
1.41M
Average Volume (3m)
699.07K
1-Year Change
4.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEGA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
34.58
Downside
-6.53%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Mega Lifesciences PCL News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Mega Lifesciences Company Profile

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products. The company also offers prescription medicines in the areas of anti-allergic, anti-infective, central nervous system, cardiovascular system, dermatology, diabetes, gastroenterology, gynecology, nephrology, oncology, ophthalmology, orthopedic, pain, respiratory, rheumatology, and urology. In addition, it provides logistical and marketing services for the sale of goods manufactured by third parties, social enterprise, and wellness center, as well as involved in the software design, development, and other services business. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited operates as a subsidiary of Unistretch Limited.

Employees
900
Market
Thailand

Mega Lifesciences PCL Earnings Call Summary for Q3/2025

  • Mega Lifesciences reported Q3 2025 revenue of 3.88B THB with EPS of 0.57 THB, meeting market expectations and driving a 2.52% stock price increase to 30.5 THB.
  • The company's branded business grew 4.3% YoY while overall revenue decline narrowed to 10.3%; gross profit margin improved to 51.8% from 49.6% in 2024.
  • Net profits reached 1,335M THB (flat YoY) with strong operating cash flows of 1.7B THB (128% of profits), demonstrating operational efficiency.
  • Management projects 2025 adjusted net profits of 1,950M THB with a dividend payout of 50-60% and aims to double the branded business within five years.
  • CEO Vivek Dhawan highlighted the company's balanced portfolio across 33 markets, with 50-60% in consumer health products and 40-50% in pharmaceuticals.
Last Updated: 24/11/2025, 17:04
Read Full Transcript

Compare MEGA to Peers and Sector

Metrics to compare
MEGA
Peers
Sector
Relationship
P/E Ratio
16.1x21.8x−0.6x
PEG Ratio
2.370.490.00
Price/Book
3.3x2.9x2.6x
Price / LTM Sales
2.2x3.6x3.3x
Upside (Analyst Target)
−6.8%17.2%39.4%
Fair Value Upside
Unlock14.2%3.9%Unlock

Analyst Ratings

4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 34.58
(-6.53% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.26%
Dividend Yield
4.32%
Industry Median 4.35%
Annualised payout
1.60
Paid unevenly
5-Years Growth
+15.75%
Growth Streak

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
0.57 / --
Revenue / Forecast
3.88B / --
EPS Revisions
Last 90 days

People Also Watch

17.70
SPALI
0.00%
15.30
AMATA
-2.55%
27.50
RCL
-1.79%
14.20
TOA
-2.74%
22.50
TVO
-1.75%

FAQ

What Is the Mega Lifesciences (MEGA) Share Price Today?

The live Mega Lifesciences share price today is 37.00

What Stock Exchange Does Mega Lifesciences (MEGA) Trade On?

Mega Lifesciences is listed and trades on the Thailand Stock Exchange.

What Is the Ticker (Stock Symbol) for Mega Lifesciences?

The stock symbol (also called a 'ticker') for Mega Lifesciences is "MEGA."

Does Mega Lifesciences Pay Dividends? What’s The Current MEGA Dividend Yield?

Yes, MEGA Pays Dividends to its Shareholders. The current Mega Lifesciences dividend yield is 4.32%.

What Is the Current Mega Lifesciences Market Cap?

As of today, Mega Lifesciences market capitalisation is 32.26B.

What Is Mega Lifesciences's (MEGA) Earnings Per Share (TTM)?

The Mega Lifesciences EPS is currently 2.26 (Trailing Twelve Months).

When Is the Next Mega Lifesciences Earnings Date?

Mega Lifesciences's next earnings report will be released on 19 Feb 2026.

Is MEGA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Mega Lifesciences moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Mega Lifesciences Stock Split?

Mega Lifesciences has split 0 times. (See the MEGA stock split history page for full effective split date and price information.)

How Many Employees Does Mega Lifesciences Have?

Mega Lifesciences has 900 employees.

What is the current trading status of Mega Lifesciences (MEGA)?

As of 08 Jan 2026, Mega Lifesciences (MEGA) is trading at a price of 37.00, with a previous close of 36.50. The stock has fluctuated within a day range of 36.25 to 37.00, while its 52-week range spans from 24.30 to 37.25.

What Is Mega Lifesciences (MEGA) Price Target According to Analysts?

The average 12-month price target for Mega Lifesciences is THB34.58333, with a high estimate of THB38 and a low estimate of THB32. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -6.53% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.